Core Viewpoint - Zhonghong Medical announced that its subsidiary, Jiangxi Kelong Medical Device Manufacturing Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration, extending the validity of the existing product registration until February 28, 2031 [1] Group 1 - The registration certificate is a continuation of the existing product registration [1] - The previous expiration date of the registration was February 28, 2026 [1] - The new effective period extends the registration by five years [1]

证券代码：300981 证券简称：中红医疗 公告编号：2025-087 中红普林医疗用品股份有限公司 关于子公司江西科伦医疗器械制造有限公司完成医疗器械 延续注册的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）子公司江西科伦医疗 器械制造有限公司于近期取得国家药品监督管理局颁发的《中华人民共和国医疗 器械注册证》，上述注册证为原有产品的延续注册，有效期限由原 2026 年 2 月 28 日到期延续至 2031 年 2 月 28 日到期。上述注册证具体情况如下： 一、基本信息 特此公告 中红普林医疗用品股份有限公司 二、对公司的影响及风险提示 上述医疗器械注册证有效期的延长，延续了公司及子公司在一次性使用输液 用肝素帽领域的产品品类，能够保证原有产品的持续销售，并将进一步增强公司 及子公司的综合竞争力，不断满足多元化的市场需求，有利于进一步提高市场拓 展能力。 上述产品实际销售情况取决于未来市场的推广效果，产品销售及利润贡献具 有不确定性，目前尚无法预测上述产品对公司未来业绩的影响，敬请投资者注意 防范投资 ...

Core Viewpoint - The company, Zhonghong Medical, is primarily engaged in the export of medical devices and consumables, utilizing an ODM direct sales model, which allows it to design and produce products for overseas brand owners [2][4]. Group 1: Company Overview - Zhonghong Medical is a state-owned enterprise controlled by the Xiamen Municipal Government State-owned Assets Supervision and Administration Commission [5]. - The company was established on December 22, 2010, and went public on April 27, 2021. Its main business includes the research, production, and sales of high-quality nitrile gloves, PVC gloves, and other disposable protective gloves [9]. - As of June 30, 2025, the company had 20,200 shareholders, with an average of 19,502 circulating shares per person, reflecting a 0.40% increase in shareholder numbers [10]. Group 2: Financial Performance - For the first half of 2025, Zhonghong Medical achieved a revenue of 1.238 billion yuan, representing a year-on-year growth of 7.76%. However, the net profit attributable to shareholders decreased by 82.35% to 5.7429 million yuan [10]. - The company's overseas revenue accounted for 81.56% of total revenue, benefiting from the depreciation of the RMB [4]. Group 3: Product and Market Development - At the 12th Beijing Pet Expo, Zhonghong Medical showcased its innovative veterinary infusion pumps, which received positive feedback for their safety and multifunctionality [2]. - The company emphasizes innovation and digital technology integration in product development, aiming to become a leading provider of intelligent medical solutions [3]. Group 4: Market Activity - On September 23, Zhonghong Medical's stock fell by 1.76%, with a trading volume of 80.3791 million yuan and a turnover rate of 1.54%, resulting in a total market capitalization of 5.73 billion yuan [1]. - The average trading cost of the stock is 14.67 yuan, with the current price approaching a resistance level of 13.54 yuan, indicating potential for upward movement if this level is surpassed [8].

Core Viewpoint - The Shanghai Stock Exchange will review the initial public offering (IPO) of Moore Threads on September 26, aiming to raise 8 billion yuan [1] Group 1: Company Overview - Moore Threads plans to list on the Sci-Tech Innovation Board and seeks to raise 8 billion yuan through its IPO [1] - The company has direct and indirect stakes in various sectors, including electronics, computers, and communications [1] - Directly invested companies include Heertai (002402) and Yingqu Technology (002925), while indirectly invested companies include Honglida, Chuling Information (300250), and Changfei Fiber (601869) [1] Group 2: Market Performance - As of September 19, the average annual increase for the directly or indirectly invested companies is nearly 35%, with Changfei Fiber and Heertai exceeding 100% [1] - Financing data shows that as of September 18, these companies have seen an overall increase of nearly 30% in financing from investors this year [1] - Six companies, including Changfei Fiber, Heertai, and Ruifeng New Materials (300910), have received over 30% increase in financing from investors [1] Group 3: Investment Backers - In addition to A-share companies, notable investors in Moore Threads include Tencent, Lenovo, Sequoia Capital, and Houshu Capital [1]

Group 1 - The core point of the article is the announcement by Zhonghong Medical (300981) regarding the election of Mr. Jia Bin as the employee representative director of the company's fourth board of directors [1]

Group 1 - The company, Zhonghong Medical (300981), announced on the evening of September 15 that it has agreed to elect non-independent director Mr. Zhan Zhihong as a member of the fourth board of directors' remuneration assessment and nomination committee [1]

Group 1 - The core point of the article is that Zhonghong Medical (SZ 300981) held a board meeting on September 15, 2025, to discuss the re-election of members for the Compensation and Assessment Committee [1] - Zhonghong Medical's revenue for the first half of 2025 was entirely derived from the medical device industry, accounting for 100% of its income [2] - As of the report, Zhonghong Medical has a market capitalization of 6 billion yuan [2]

证券代码：300981 证券简称：中红医疗 公告编号：2025-083 中红普林医疗用品股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东大会没有出现否决提案的情形。 2. 本次股东大会不涉及变更以往股东大会已通过决议的情形。 一、会议召开情况和出席情况 1. 会议召开时间： 现场会议召开时间：2025 年 9 月 15 日（星期一）14:30； 网络投票时间：2025 年 9 月 15 日。其中，通过深交所交易系统进行网络投 票的时间为 2025 年 9 月 15 日 9:15－9:25，9:30－11:30 和 13:00－15:00；通 过深圳证券交易所互联网系统投票的具体时间为2025年9月15日9:15－15:00。 2. 现场会议召开地点：北京经济技术开发区科创六街 87 号四楼会议室。 3. 会议召开方式：现场表决与网络投票相结合的方式。 4. 会议召集人：公司董事会。 5. 会议主持人：董事长桑树军先生。 6. 本次股东大会的召集及召开符合《中华人民共和国公司法》《中 ...

北京德恒律师事务所 关于中红普林医疗用品股份有限公司 2025 年第三次临时股东大会的 法律意见 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 北京德恒律师事务所 关于中红普林医疗用品股份有限公司 2025 年第三次临时股东大会的法律意见 北京德恒律师事务所 关于中红普林医疗用品股份有限公司 法律意见 德恒 01G20250295-03 号 致：中红普林医疗用品股份有限公司 中红普林医疗用品股份有限公司（以下简称"公司"）2025 年第三次临时 股东大会（以下简称"本次会议"）于 2025 年 9 月 15 日（星期一）召开。北京 德恒律师事务所（以下简称"德恒"）受公司委托，指派吴莲花律师、荣秋立律 师（以下简称"德恒律师"），根据《中华人民共和国证券法》（以下简称"《证 券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、中国证 券监督管理委员会《上市公司股东会规则》（以下简称"《股东会规则》"）、 《中红普林医疗用品股份有限公司章程》（以下简称"《公司章程》"）的规定， 就本次会议的召集、召开程序、 ...

特此公告 中红普林医疗用品股份有限公司 证券代码：300981 证券简称：中红医疗 公告编号：2025-086 中红普林医疗用品股份有限公司 关于公司补选薪酬考核与提名委员会委员的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 2025 年 9 月 15 日，中红普林医疗用品股份有限公司（以下简称"公司"） 召开了第四届董事会第十二次会议，审议通过了《关于补选薪酬考核与提名委员 会委员的议案》，同意补选非独立董事詹志东先生（简历见附件）为公司第四届 董事会薪酬考核与提名委员会委员，与张旭东先生（主任委员）、杜汋先生共同 组成第四届董事会薪酬考核与提名委员会，上述任期自本次董事会审议通过之日 起至第四届董事会任期结束之日止。 詹志东先生，男，1974 年出生，中国国籍，无境外永久居住权，高级管理 人员工商管理硕士，高级经济师。曾任厦门国贸资产运营集团有限公司总经理， 厦门国贸会展集团有限公司董事长、总经理，厦门国贸控股集团有限公司董事、 战略投资总监、战略运营管理部总经理、总经理助理等职。现任厦门国贸控股集 团有限公司副总经理，中红普林集团有限公司董事长， ...